CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a multifunctional nanomedicine for targeted cancer therapy using a pH-responsive nanocarrier. It seeks to enhance drug delivery and reduce side effects by integrating chemotherapy with imaging capabilities, addressing challenges like drug resistance in cancer treatment.
Cancer is a leading cause of death worldwide, accounting for 7.6 million deaths in 2008.
Although conventional cancer chemotherapy can provide profound benefits, seriously adverse side-effects still cannot be avoided, due to lack of specific targeting nature of current treatments.
Nanomedicine can reduce such side-effects by exploiting characteristic properties of tumors for targeted delivery and therapy.
Despite extensive research, most nanomedicines developed so far have relied on passive targ…
UNIVERSITY OF LEEDS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
